Titlebook: Caring for Patients with Mesothelioma: Principles and Guidelines; Mary Hesdorffer,Gleneara E. Bates-Pappas Book 2019 Springer Nature Switz

EFFCT

書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines影響因子(影響力)




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines影響因子(影響力)學(xué)科排名




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines網(wǎng)絡(luò)公開度




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines被引頻次




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines被引頻次學(xué)科排名




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines年度引用




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines年度引用學(xué)科排名




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines讀者反饋




書目名稱Caring for Patients with Mesothelioma: Principles and Guidelines讀者反饋學(xué)科排名

生氣地

History Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasi the administration of intraoperative chemotherapy to treat microscopic disease. Key principles include removing all macroscopic disease and then administering heated mitomycin C or a platinum-based chemotherapeutic agent intraperitoneal for 90–120 minutes intraoperatively. The addition of hyperther

Extort

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesotheedian survival in the past was estimated at 1?year. Most recent reports show median survival not reached and a 5-year survival estimated at 70%. The treatments that may be offered to the MPM patient are cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and normothermic

Stress-Fracture

Radiation Therapylity treatment approach in conjunction with chemotherapy and surgery in an attempt to control the disease locally. The complex anatomy of the pleura and its proximity to vital organs at risk, such as the lungs, heart, esophagus, and brachial plexus, pose distinct challenges. Novel techniques such as

escalate

Chemotherapy and Standard Treatment Optionscould stretch to the size of an entire book, but unfortunately, in malignant mesothelioma, to date, there is only one FDA-approved treatment and no approved second-line treatment. Providing a weighty chapter is impossible in a disease, which historically has had little in the way of developments sin

PSA-velocity

PSA-velocity

Biotherapy Treatment: Mesothelin-Targeted Therapiess well as other cancers including pancreas, ovarian, and lung cancer. A number of agents have been evaluated as potential treatments for malignant mesothelioma, including immunotoxins, monoclonal antibodies, antibody drug conjugates, vaccines, and chimeric antigen receptor T cells (CAR-T cells). Eac

microscopic

Care of the?Mesothelioma Patient Undergoing Extended Pleurectomy and Decorticationled, and dedicated multidisciplinary team of thoracic surgery experts to care for these patients and their families. There are inherent challenges associated with the preoperative and postoperative care of patients undergoing lung-sparing surgery, beyond those commonly experienced in the general tho

Baffle

Maintaining a Nutritional Diet During and After Active Treatment 12?years that I have worked as a nurse, I have watched and learned the types of nutrition that best facilitate healing in patients recovering from surgery, chemotherapy, and radiation. As a healthcare professional, I quickly learned that an individual’s diet and nutrition was not only the key to on

山羊